Alpine Immune Sc Stock Price, News & Analysis
Company Description
Alpine Immune Sc (NASDAQ: ALPN) is a publicly traded pharmaceutical preparation manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $4.5B, ranking #1,495 among all listed U.S. companies by market cap.
ALPN stock has declined 100.0% over the past year. Shares last traded at $64.97.
This page provides a comprehensive overview of ALPN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Alpine Immune Sc (ALPN) stock last traded at $64.97. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $4.5B, ALPN is classified as a mid-cap stock with approximately 68.6M shares outstanding.
Latest News
Alpine Immune Sc has 10 recent news articles. Of the recent coverage, 8 articles coincided with positive price movement and 1 with negative movement. Key topics include management, earnings, clinical trial, acquisition, conferences. View all ALPN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ALPN Company Profile & Sector Positioning
Alpine Immune Sc (ALPN) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.